160 related articles for article (PubMed ID: 1648959)
21. Loss of heterozygosity at 11p13 in Wilms' tumours does not necessarily involve mutations in the WT1 gene.
Cowell JK; Groves N; Baird P
Br J Cancer; 1993 Jun; 67(6):1259-61. PubMed ID: 8390282
[TBL] [Abstract][Full Text] [Related]
22. The distal region of 11p13 and associated genetic diseases.
Mannens M; Hoovers JM; Bleeker-Wagemakers EM; Redeker E; Bliek J; Overbeeke-Melkert M; Saunders G; Williams B; van Heyningen V; Junien C
Genomics; 1991 Oct; 11(2):284-93. PubMed ID: 1769647
[TBL] [Abstract][Full Text] [Related]
23. Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.
Gessler M; König A; Arden K; Grundy P; Orkin S; Sallan S; Peters C; Ruyle S; Mandell J; Li F
Hum Mutat; 1994; 3(3):212-22. PubMed ID: 8019557
[TBL] [Abstract][Full Text] [Related]
24. CpG islands surround a DNA segment located between translocation breakpoints associated with genitourinary dysplasia and aniridia.
Bickmore WA; Porteous DJ; Christie S; Seawright A; Fletcher JM; Maule JC; Couillin P; Junien C; Hastie ND; van Heyningen V
Genomics; 1989 Nov; 5(4):685-93. PubMed ID: 2556343
[TBL] [Abstract][Full Text] [Related]
25. [Hereditary renal tumors: Wilms' tumor--congenital anomalies' syndrome].
Tsuchida Y; Yokomori K; Choi SH
Nihon Rinsho; 1995 Nov; 53(11):2742-8. PubMed ID: 8538037
[TBL] [Abstract][Full Text] [Related]
26. The chromosome 11 region flanking the t(11;14) breakpoint in human T-ALL is deleted in Wilms' tumor hybrids.
Finver SN; Martiniere C; Kagan J; Cavenee W; Croce CM
Oncogene Res; 1989; 5(2):143-8. PubMed ID: 2558334
[TBL] [Abstract][Full Text] [Related]
27. Inactivation of the remaining allele of the WT1 gene in a Wilms' tumour from a WAGR patient.
Brown KW; Watson JE; Poirier V; Mott MG; Berry PJ; Maitland NJ
Oncogene; 1992 Apr; 7(4):763-8. PubMed ID: 1314370
[TBL] [Abstract][Full Text] [Related]
28. Loss of heterozygosity in Wilms' tumour involves two distinct regions of chromosome 11.
Wadey RB; Pal N; Buckle B; Yeomans E; Pritchard J; Cowell JK
Oncogene; 1990 Jun; 5(6):901-7. PubMed ID: 2163053
[TBL] [Abstract][Full Text] [Related]
29. Aniridia, gonadoblastoma, Wilms' tumor and deletion 11p13.
Stefan H; Semecký V
Acta Medica (Hradec Kralove); 1998; 41(1):29-33. PubMed ID: 9588071
[TBL] [Abstract][Full Text] [Related]
30. Polymerase chain reaction-based risk assessment for Wilms tumor in sporadic aniridia.
Gupta SK; De Becker I; Guernsey DL; Neumann PE
Am J Ophthalmol; 1998 May; 125(5):687-92. PubMed ID: 9625553
[TBL] [Abstract][Full Text] [Related]
31. Intragenic homozygous deletion of the WT1 gene in Wilms' tumor.
Tadokoro K; Fujii H; Ohshima A; Kakizawa Y; Shimizu K; Sakai A; Sumiyoshi K; Inoue T; Hayashi Y; Yamada M
Oncogene; 1992 Jun; 7(6):1215-21. PubMed ID: 1350671
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of chromosome 11p imbalances in aniridia and Wilms tumor patients.
Busch M; Leube B; Thiel A; Schanze I; Beier M; Royer-Pokora B
Am J Med Genet A; 2013 May; 161A(5):958-64. PubMed ID: 23494989
[TBL] [Abstract][Full Text] [Related]
33. A third Wilms' tumor locus on chromosome 16q.
Maw MA; Grundy PE; Millow LJ; Eccles MR; Dunn RS; Smith PJ; Feinberg AP; Law DJ; Paterson MC; Telzerow PE
Cancer Res; 1992 Jun; 52(11):3094-8. PubMed ID: 1317258
[TBL] [Abstract][Full Text] [Related]
34. Loss of allelic heterozygosity at a second locus on chromosome 11 in sporadic Wilms' tumor cells.
Reeve AE; Sih SA; Raizis AM; Feinberg AP
Mol Cell Biol; 1989 Apr; 9(4):1799-803. PubMed ID: 2542777
[TBL] [Abstract][Full Text] [Related]
35. Homozygous inactivation of WT1 in a Wilms' tumor associated with the WAGR syndrome.
Gessler M; König A; Moore J; Qualman S; Arden K; Cavenee W; Bruns G
Genes Chromosomes Cancer; 1993 Jul; 7(3):131-6. PubMed ID: 7687865
[TBL] [Abstract][Full Text] [Related]
36. Raised risk of Wilms tumour in patients with aniridia and submicroscopic WT1 deletion.
van Heyningen V; Hoovers JM; de Kraker J; Crolla JA
J Med Genet; 2007 Dec; 44(12):787-90. PubMed ID: 17630404
[TBL] [Abstract][Full Text] [Related]
37. Identical genetic changes in different histologic components of Wilms' tumors.
Zhuang Z; Merino MJ; Vortmeyer AO; Bryant B; Lash AE; Wang C; Deavers MT; Shelton WF; Kapur S; Chandra RS
J Natl Cancer Inst; 1997 Aug; 89(15):1148-52. PubMed ID: 9262253
[TBL] [Abstract][Full Text] [Related]
38. Deletion of WT1 and WIT1 genes and loss of heterozygosity on chromosome 11p in Wilms tumors in Japan.
Kaneko Y; Takeda O; Homma C; Maseki N; Miyoshi H; Tsunematsu Y; Williams BG; Saunders GF; Sakurai M
Jpn J Cancer Res; 1993 Jun; 84(6):616-24. PubMed ID: 8393432
[TBL] [Abstract][Full Text] [Related]
39. Wilms tumor locus on 11p13 defined by multiple CpG island-associated transcripts.
Bonetta L; Kuehn SE; Huang A; Law DJ; Kalikin LM; Koi M; Reeve AE; Brownstein BH; Yeger H; Williams BR
Science; 1990 Nov; 250(4983):994-7. PubMed ID: 2173146
[TBL] [Abstract][Full Text] [Related]
40. Telomere fusion as a mechanism for the progressive loss of the short arm of chromosome 11 in an anaplastic Wilms' tumor.
Sawyer JR; Goosen LS; Stine KC; Thomas JR
Cancer; 1994 Jul; 74(2):767-73. PubMed ID: 8033058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
